Articles From: Mecox Lane Announces Shareholder Resolutions Adopted at 2013 Annual General Meeting to Medgenics Launches First Clinical Trial in Hepatitis to Use INFRADURE Tissue Treatment


2013/5/10
SHANGHAI, China, May 10, 2013 (GLOBE NEWSWIRE) -- Mecox Lane Limited ("Mecox Lane" or the "Company") (Nasdaq:MCOX) , a leading brand and multi-channel retailer of apparel and accessories in China, today announced that the following shareholder resolutions were adopted at its annual general meeting of shareholders held in Hong Kong on May 10, 2013.
Sign-up for Mecox Lane Announces Shareholder Resolutions Adopted at 2013 Annual General Meeting investment picks
2013/5/15
SHANGHAI, China, May 15, 2013 (GLOBE NEWSWIRE) -- Mecox Lane Limited ("Mecox Lane" or the "Company") (Nasdaq:MCOX) , a leading brand and multi-channel retailer of apparel and accessories in China, today announced its unaudited financial results for the first quarter ended March 31, 2013.
Sign-up for Mecox Lane Limited Announces First Quarter 2013 Results investment picks
2013/3/4
SHANGHAI, China, March 4, 2013 (GLOBE NEWSWIRE) -- Mecox Lane Limited ("Mecox Lane" or the "Company") (Nasdaq:MCOX) , a leading brand and multi-channel retailer of apparel and accessories in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2012.
Sign-up for Mecox Lane Limited Announces Fourth Quarter and Full Year 2012 Results investment picks
2013/4/22
SHANGHAI, China, April 22, 2013 (GLOBE NEWSWIRE) -- Mecox Lane Limited ("Mecox Lane" or the "Company") (Nasdaq:MCOX) , a leading brand and multi-channel retailer of apparel and accessories in China, today announced that its annual general meeting ("AGM") will be held on Friday, May 10, 2013 at 10:00 AM (Hong Kong time) at 18th Floor, One Exchange Square, 8 Connaught Place, Central, Hong Kong.
Sign-up for Mecox Lane Limited Announces Notice of Annual General Meeting investment picks
2013/4/23
SHANGHAI, China, April 23, 2013 (GLOBE NEWSWIRE) -- Mecox Lane Limited ("Mecox Lane" or the "Company") (Nasdaq:MCOX) , a leading brand and multi-channel retailer of apparel and accessories in China, today announced that it filed its annual report on Form 20-F for the year ended December 31, 2012 with the Securities and Exchange Commission today.
Sign-up for Mecox Lane Limited Files Annual Report on Form 20-F investment picks
2013/5/9
SHANGHAI, China, May 9, 2013 (GLOBE NEWSWIRE) -- Mecox Lane Limited ("Mecox Lane" or the "Company") (Nasdaq:MCOX) , a leading brand and multi-channel retailer of apparel and accessories in China, today announced that the Company will report its financial results for the first quarter ended March 31, 2013 on Wednesday, May 15, 2013, after the U.S. markets close.
Sign-up for Mecox Lane Limited to Announce First Quarter 2013 Results on May 15, 2013 investment picks
2013/2/27
SHANGHAI, China, Feb.
Sign-up for Mecox Lane Limited to Announce Fourth Quarter and Full Year 2012 Results on March 4, 2013 investment picks
2013/4/25
According to the latest Bauer Financial Inc. bank ratings as of December 31, 2012, Medallion Bank was ranked in the top 1% of all FDIC insured banks nationwide in terms of its return on assets for 2012.
Sign-up for Medallion Bank Rated in the Top 1% for Return on Assets investment picks
2013/3/5
Medallion Financial Corp.
Sign-up for Medallion Financial Corp. Reports 2012 Fourth Quarter and Record Full Year Results investment picks
2013/5/6
Medallion Financial Corp.
Sign-up for Medallion Financial Corp. Reports 2013 First Quarter Results investment picks
2013/3/28
MedAssets (NASDAQ: MDAS) today announced a multi-year agreement with Kettering Health Network (Kettering) in which the company will continue to support the health system to standardize and optimize its revenue cycle processes and workflow.
Sign-up for MedAssets and Kettering Health Network Renew Agreement to Further Optimize Revenue Cycle Performance across Growing Health System investment picks
2013/2/21
MedAssets (NASDAQ: MDAS) announced today that The Resource Group, a subsidiary of Ascension Health Alliance, signed a contract renewal that continues a long-standing business relationship.
Sign-up for MedAssets and The Resource Group Renew System-Wide Cost Management Relationship investment picks
2013/5/13
MedAssets, Inc. today announced that the call for exhibitors is now open for the 2013 Technology & Innovation Forum, scheduled to be held on Tuesday, Oct.
Sign-up for MedAssets Announces Call for Exhibitors for 2013 Technology & Innovation Forum investment picks
2013/4/8
MedAssets, Inc. (NASDAQ: MDAS) today announced a multi-year strategic partnership with Ariba , an SAP company, that significantly expands MedAssets industry-leading supply chain management and outsourced procurement capabilities.
Sign-up for MedAssets Enters into Strategic Partnership with Ariba investment picks
2013/4/4
MedAssets (NASDAQ: MDAS) today announced that University Health System has received the 2012 MedAssets President’s Award.
Sign-up for MedAssets Honors Healthcare Providers and Suppliers for 2012 Achievements in Improving Care Quality and Efficiency investment picks
2013/4/9
MedAssets (NASDAQ: MDAS) today announced the recipients of the 2012 George Herbert Walker Bush Pacesetter Award and 2012 Norman Borlaug Humanitarian Award , which were presented during the 2013 MedAssets Healthcare Business Summit , held April 2-4 in Las Vegas.
Sign-up for MedAssets Recognizes Veteran U.S. Army Airborne Ranger Sean Parnell, Humanitarians Linda Egle, Jamie and Ali McMutrie for Dedicated Public Service investment picks
2013/5/1
MedAssets, Inc. (NASDAQ: MDAS) today announced results for its first quarter ended March 31, 2013.
Sign-up for MedAssets Reports First Quarter 2013 Financial Results investment picks
2013/2/20
MedAssets, Inc. (NASDAQ: MDAS) today announced results for its fourth quarter and full year ended December 31, 2012.
Sign-up for MedAssets Reports Fourth Quarter and Full-Year 2012 Financial Results investment picks
2013/5/15
MedAssets (NASDAQ: MDAS) today announced that the company will be participating in the National Association of Healthcare Access Management (NAHAM) 39 th Annual Educational Conference and Exposition , to be held at the Hyatt Regency Atlanta from May 15-18, 2013.
Sign-up for MedAssets Showcases Patient Access Management Solutions at NAHAM 39th Annual Educational Conference and Exposition investment picks
2013/3/1
MedAssets, Inc. (NASDAQ: MDAS) announced that its management team will present at the Raymond James 34 th Annual Institutional Investors Conference on Monday, March 4, 2013 at 2:50 pm ET in Orlando.
Sign-up for MedAssets to Present at the Raymond James 34th Annual Institutional Investors Conference on March 4, 2013 investment picks
2013/5/6
MedAssets, Inc. (NASDAQ: MDAS) today announced that its management team will participate in two investment conferences during the month of May.
Sign-up for MedAssets to Present at Two Investment Conferences on May 14 and 21, 2013 investment picks
2013/4/11
MedAssets, Inc. (NASDAQ: MDAS) today announced that it plans to release its financial results for the first quarter ended March 31, 2013 after 4:00 p.m. ET on Wednesday, May 1, 2013.
Sign-up for MedAssets to Report First Quarter 2013 Financial Results on Wednesday, May 1st after 4:00 p.m. ET investment picks
2013/2/12
MedAssets, Inc. (NASDAQ: MDAS) today announced that it will webcast its 2013 Investor Day meeting on Thursday, February 28, 2013.
Sign-up for MedAssets to Webcast its 2013 Investor Day on February 28th investment picks
2013/2/26
ADVISORY, Feb.
Sign-up for MedAssets, Inc. [MDAS] and Hire Heroes USA to Ring The NASDAQ Stock Market Closing Bell investment picks
2013/2/28
New Leadership, Focused on Realizing Shareholder Value BETHLEHEM, Pa.
Sign-up for MedClean Technologies Announces New Chairman, CEO investment picks
2013/2/14
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the “Company” or “Medgenics”), the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces yesterday’s closing of an underwritten public offering of 5,600,000 shares of common stock and Series 2013-A warrants to purchase up to an aggregate of 2,800,000 shares of common stock.
Sign-up for Medgenics Announces Closing of Public Offering of Common Stock and Warrants investment picks
2013/3/26
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the “Company” or “Medgenics”), the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that, in connection with its previously announced public offering, the underwriters have exercised their option to purchase 470,000 shares of common stock at $5.24 per share and 840,000 Series 2013-A warrants (the Warrants) at $0.01 per Warrant, which allows for the purchase of 420,000 shares of Common Stock at an initial exercise price of $6.78. The Warrants are currently exercisable and will expire February 13, 2018.
Sign-up for Medgenics Announces Exercise by Underwriters of Over-Allotment Option investment picks
2013/5/1
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the “Company” or “Medgenics”),, the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announces that all resolutions proposed at the Company’s Annual Meeting of Stockholders held yesterday were duly passed.
Sign-up for Medgenics Announces Results of 2013 Annual Meeting of Stockholders investment picks
2013/3/12
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the “Company” or “Medgenics”), the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces the appointment of Joseph J.
Sign-up for Medgenics Appoints Former Chairman and CEO of UBS Financial Services Joseph J. Grano, Jr. to Board of Directors investment picks
2013/1/30
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announced today that the first patient has been enrolled in a Phase I/II clinical trial with the Company’s INFRADURE™ Biopump™ for the treatment of hepatitis C.
Sign-up for Medgenics Launches First Clinical Trial in Hepatitis to Use INFRADURE Tissue Treatment investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Mecox Lane Announces Shareholder Resolutions Adopted at 2013 Annual General Meeting to Medgenics Launches First Clinical Trial in Hepatitis to Use INFRADURE Tissue Treatment
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity